Categorization of drug development projects

Main Article Content

Magdalena Marciniak
Paweł Cabała

Abstract

The aim of the article is to develop a categorization of drug development projects based on the identified determinants of project management at different stages of the drug development process. The authors assumed that the factors influencing the success of drug development project management are diverse and depend on the level of advancement of research work. The concept of Technology Readiness Levels, which is well operationalized and applied in a wide range of industrial sectors, was used as a benchmark for assessing the maturity of projects. The complex, costly and multi-stage drug discovery and development process has been referred to Technology Readiness Levels. To define the determinants of drug development project management, empirical material collected through the observation of 140 meetings of teams implementing a total of 7 projects with different levels of development work was used. The presented research results can be used for the stratification of drug development projects, which – thanks to the use of appropriately selected project management methods – will enable better organization of the work of R&D centers in the biotechnology and pharmaceutical industries.

Downloads

Article Details

How to Cite
Marciniak, M., & Cabała, P. (2025). Categorization of drug development projects. Journal of Management and Financial Sciences, (52), 29–43. https://doi.org/10.33119/JMFS.2024.52.2
Section
Articles

References

Antonijevic, Z. (2014). Optimization of Pharmaceutical R&D Programs and Portfolios. Springer International Publishing AG. ISBN: 9783319090740.

Bode-Greuel, K., Nickisch, K. (2008). Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice. J Commer Biotechnol, 14, pp. 307–325. https://doi.org/10.1057/jcb.2008.6

Bukowski, H., Gierczyński, J. (2019). Przełomowe innowacje farmaceutyczne – doświadczenia, rekomendacje, perspektywy. Raport INFARMA. Instytut Innowacyjna Gospodarka.

Chaguturu, R. (2014). Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships. John Wiley & Sons. ISBN: 9780470917374.

Chen, J. L. (2018). Drug discovery and drug marketing with the critical roles of modern administration. American Journal of Translational Research, 10 (12), p. 4302

Cybulska, D. (2013). Wykorzystanie metody obserwacji w naukach społecznych. Obronność – Zeszyty Naukowe Wydziału Zarządzania i Dowodzenia Akademii Obrony Narodowej, 2 (6), pp. 20–31

Department of Defense United States of America. (2009, July). Technology Readiness Assessment (TRA) Deskbook.

Fisher, J., Klein, Ch., Childers, W. E. (2021). Successful Drug discovery, 5 (2021). Wiley. ISBN:3527347542.

González Peña, O. I., López Zavala, M. Á., Cabral Ruelas, H. (2021). Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater. International Journal of Environmental Research and Public Health,

(5), p. 2532. https://doi.org/10.3390/ijerph18052532

Jemielniak, D. (2023). Badania Jakościowe. Tom 1. PWN. ISBN: 9788301169459.

Kim, E., Yang, J., Park, S., Shin, K. (2023). Factors Affecting Success of New Drug Clinical Trials. Therapeutic Innovation & Regulatory Science, 57 (4), pp. 737–750. https://doi.org/10.1007/ s43441-023-00509-1

Matthews, M., Hamoni, R., Watson, M. (2023). Digital Transformation: The Next Big Leap in Healthcare, https://ssrn.com/abstract=4501812

Ng, R. (2015). Drugs: From Discovery to Approval. John Wiley & Sons Inc.

Paul, S. M. et al. (2010). How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nature Reviews Drug Discovery, 9, pp. 203–214.

Poduri, R. (2021). Drug Discovery and Development, From Targets and Molecules to Medicines. Springer. ISBN: 9811555338.

Ravina, E. (2011). The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. Wiley. ISBN-13: 9783527326693.

Schuhmacher, A., Gassmann, O., Bieniok, D., Hinder, M., Hartl, D. (2022). Open innovation: A paradigm shift in pharma R&D? Drug Discovery Today, 27 (9), pp. 2395–2405, https://doi.org/10.1016/j.drudis.2022.05.018

Stalder, J. (2022). Project Management for Drug Developers. CRC Press Inc. ISBN: 9781032126685

Sztumski, J. (2005). Wstęp do metod i technik badań społecznych. Katowice: Wydawnictwo Naukowe „Śląsk”, pp. 149–150.

Szuchalska, A. (2020). Obserwacja uczestnicząca na lekcjach językowych – korzyści i ograniczenia. Linguodidactica XXIV. DOI: 10.15290/lingdid.2020.24.19.

Teramae, F., Makino, T., Lim, Y., Sengoku, S., Kodama, K. (2020). Impact of Research and Development Strategy on Sustainable Growth in Multinational Pharmaceutical Companies. Sustainability, 12 (13), 5358, https://doi.org/10.3390/su12135358

Wysocki, R. K. (2009). Effective Project Management: Traditional, Agile, Extreme. Indianapolis: Wiley Publishing, Inc.

Web pages:

https://euraxess.ec.europa.eu

https://www.ema.europa.eu/en

https://www.fda.gov/

www.nasa.gov